NEW YORK (GenomeWeb) – The year 2015 was a busy one for the genomics research tools and molecular diagnostics industries with an uptick in mergers and acquisitions, the unveiling of highly anticipated platforms and upgrades, and growing interest in NIPT and liquid biopsy technologies. Among the most-read articles on the GenomeWeb site for the year were those looking into the false-positive rates of NIPT, the naming of a panel to lead President Obama's Precision Medicine Initiative, and two articles on Oxford Nanopore.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.